by Christopher Freeburn | April 25, 2014 9:38 am
On Friday, AbbVie (ABBV) reported higher quarterly earnings and revenues. ABBV stock rose more than 3% in morning trading.
ABBV shares moved higher after the pharmaceutical-maker said it earned $980 million during the first quarter, up 1.2% from $968 million in the prior-year period. Adjusted EPS came in at 71 cents, beating guidance issued earlier this year, Reuters noted.
Quarterly sales climbed to $4.56 billion, up 5.4% over the year-ago period, and topping the $4.33 billion that Wall Street was expecting.
AbbVie said that its first quarter results were boosted by a 18% jump in worldwide sales of its rheumatoid arthritis drug, Humira, the Wall Street Journal noted. During the quarter, global Humira sales hit $2.6 billion.
On Thursday, AbbVie stock closed at $49.32 per share.
More Stocks in the News:
Source URL: http://investorplace.com/2014/04/abbv-abbvie-beats-street-soaring-humira-sales/
Short URL: http://invstplc.com/1k0Rx7M
Copyright ©2015 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.